Biochips Market

Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the same. Thus, they help in cost and time saving.

Biochips Market contains market size and forecasts of Biochips in global, including the following market information:

Global Biochips Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Biochips Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Biochips companies in 2021 (%)

The global Biochips market was valued at 9777.5 million in 2021 and is projected to reach US$ 17540 million by 2028, at a CAGR of 8.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

DNA Chip Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biochips include Abbott, Agilent Technologies, Illumina, PerkinElmer, Thermo Fisher Scientific, BioChain, Bio-Rad Laboratories, Cepheid and EMD Millipore, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biochips manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biochips Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biochips Market Segment Percentages, by Type, 2021 (%)

DNA Chip

Lab-on-a-Chip

Protein Chip

Others

Global Biochips Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biochips Market Segment Percentages, by Application, 2021 (%)

Biotechnology and Pharmaceutical Companies

Hospitals and Diagnostics Centers

Academic & Research Institutes

Other End Users

Global Biochips Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biochips Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biochips revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Biochips revenues share in global market, 2021 (%)

Key companies Biochips sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Biochips sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott

Agilent Technologies

Illumina

PerkinElmer

Thermo Fisher Scientific

BioChain

Bio-Rad Laboratories

Cepheid

EMD Millipore

Fluidigm

SuperBioChips Laboratories

US Biomax

Roche Diagnostics